• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Current and Resolved Drug Shortages and Discontinuations Reported to FDA

    FIRSTWORDPHARMA

    Current and Resolved Drug Shortages and Discontinuations Reported to FDA

    FIRSTWORDPHARMA

    Ajanta Pharma Generic Asenapine Receives Approval in US

    FDA

    Seton Pharmaceuticals`s Generic Captopril Receives Approval in US

    FDA

    Anvisa Suspends and Interdicts 13 Batches of Medicines

    ANVISA

    Taste acceptance of Captopril and Furosemide Extemporaneous Oral Pediatric

    PHARMA-EXCIPIENTS

    Taste acceptance of Captopril and Furosemide Extemporaneous Oral Formulation

    PHARMA-EXCIPIENTS

    Rusan Pharma Ltd fails EDQM Inspection

    EDQM

    Restricted lot of Captopril 25 mg

    ANVISA

    Heart drugs often unavailable or unaffordable

    REUTERS

    Suspended lots of company drugs Prati Donaduzzi

    ANVISA

    Two drugs manufactured by Wockhardt recalled in the US

    THE ECONOMIC TIMES

    Blenheim Pharmacal, Inc. initiates Class II recall of Captopril Tablets, due to cGMP deviations

    FDA

    Class II recall of Captopril Tablets, USP 12.5 mg by Wockhardt USA Inc.

    FDA

    Millions To Be Made On...Generic Drugs?

    FORBES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.